Skip to main content
Top
Published in: International Cancer Conference Journal 2/2019

01-04-2019 | Computed Tomography | Case report

A case of pulmonary artery intimal sarcoma successfully treated using concurrent chemoradiotherapy and subsequent chemotherapy

Authors: Terumi Aso, Masako Terao, Hisashi Endo, Masahiro Tabata

Published in: International Cancer Conference Journal | Issue 2/2019

Login to get access

Abstract

Pulmonary artery intimal sarcoma (PAIS) is a rare malignancy with an extremely poor prognosis. A 43-year-old man visited our hospital with shortness of breath and suddenly experienced cardiopulmonary arrest before he could be examined. After prompt resuscitation, we diagnosed PAIS, but the patient refused to undergo surgery because of the high perioperative mortality risk. Thus, the patient was treated using concurrent chemoradiotherapy with weekly paclitaxel therapy, as well as subsequent chemotherapy. The patient continued chemotherapy for 36 months until he elected to discontinue treatment. To the best of our knowledge, this is the first case of PAIS, which is difficult to resect, that was successfully treated using concurrent chemoradiotherapy and subsequent chemotherapy.
Literature
1.
go back to reference Mandelstamm M (1923) Uber primare Neubildungen des Herzens. Virchows Arch Pathol Anat 245:43–45CrossRef Mandelstamm M (1923) Uber primare Neubildungen des Herzens. Virchows Arch Pathol Anat 245:43–45CrossRef
2.
go back to reference Bandyopadhyay D, Panchabhai TS, Bajaj NS et al (2016) Primary pulmonary artery sarcoma: a close associate of pulmonary embolism- 20-year observational analysis. J Thorac Dis 8:2592–2601CrossRefPubMedCentralPubMed Bandyopadhyay D, Panchabhai TS, Bajaj NS et al (2016) Primary pulmonary artery sarcoma: a close associate of pulmonary embolism- 20-year observational analysis. J Thorac Dis 8:2592–2601CrossRefPubMedCentralPubMed
3.
go back to reference Wong HH, Gounaris I, McCormack A et al (2015) Presentation and management of pulmonary artery sarcoma. Clin Waarcoma Res 5:3CrossRef Wong HH, Gounaris I, McCormack A et al (2015) Presentation and management of pulmonary artery sarcoma. Clin Waarcoma Res 5:3CrossRef
4.
go back to reference Mussot S, Ghigna MR, Mercier O et al (2013) Retrospective institutional study of 31 patients treated for pulmonary artery sarcoma. Eur J Cardiothorac Surg 43:787–793CrossRefPubMed Mussot S, Ghigna MR, Mercier O et al (2013) Retrospective institutional study of 31 patients treated for pulmonary artery sarcoma. Eur J Cardiothorac Surg 43:787–793CrossRefPubMed
5.
go back to reference Parish JM, Rosenow EC 3rd, Swensen SJ et al (1996) Pulmonary artery sarcoma. Clinical features. Chest 110:1480–1488CrossRefPubMed Parish JM, Rosenow EC 3rd, Swensen SJ et al (1996) Pulmonary artery sarcoma. Clinical features. Chest 110:1480–1488CrossRefPubMed
6.
go back to reference Kurger I, Borowski A, Horst M et al (1990) Symptoms, diagnosis, and therapy of primary sarcoma of the pulmonary artery. Thorac Cardiovasc Surg 38:91–95CrossRef Kurger I, Borowski A, Horst M et al (1990) Symptoms, diagnosis, and therapy of primary sarcoma of the pulmonary artery. Thorac Cardiovasc Surg 38:91–95CrossRef
7.
go back to reference Travis WD, Brambilla E, Burke AP et al (2015) WHO classification of tumours of lung, pleura, thymus & heart. 4th edn. IARC Press, Lyon, pp 28–129 Travis WD, Brambilla E, Burke AP et al (2015) WHO classification of tumours of lung, pleura, thymus & heart. 4th edn. IARC Press, Lyon, pp 28–129
8.
9.
go back to reference Lee Y, Kim HJ, Yoon H et al (2016) Clinical characteristics and treatment outcomes of primary pulmonary artery sarcoma in Korea. J Korean Med Sci 31:1755–1760CrossRefPubMedCentralPubMed Lee Y, Kim HJ, Yoon H et al (2016) Clinical characteristics and treatment outcomes of primary pulmonary artery sarcoma in Korea. J Korean Med Sci 31:1755–1760CrossRefPubMedCentralPubMed
10.
go back to reference Ote EL, Oriuchi N, Miyashita G et al (2011) Pulmonary artery intimal sarcoma: the role of 18F-fluorodeoxyglucose positron emission tomography in monitoring response to treatment. Jpn J Radiol 29:279–282CrossRefPubMed Ote EL, Oriuchi N, Miyashita G et al (2011) Pulmonary artery intimal sarcoma: the role of 18F-fluorodeoxyglucose positron emission tomography in monitoring response to treatment. Jpn J Radiol 29:279–282CrossRefPubMed
11.
go back to reference Yeung DF, Johnston A, Simmons C et al (2018) Multimodality imaging of a pulmonary artery sarcoma. Echocardiography 35:123–125CrossRefPubMed Yeung DF, Johnston A, Simmons C et al (2018) Multimodality imaging of a pulmonary artery sarcoma. Echocardiography 35:123–125CrossRefPubMed
12.
go back to reference Hmelik S, Dobrenic M, Huic D (2018) F-18 FDG PET/CT in pulmonary artery sarcoma: clinical vignette. Nucl Med Rev Cent East Eur 21:48–49CrossRefPubMed Hmelik S, Dobrenic M, Huic D (2018) F-18 FDG PET/CT in pulmonary artery sarcoma: clinical vignette. Nucl Med Rev Cent East Eur 21:48–49CrossRefPubMed
13.
go back to reference Blackman SH, Rice DC, Correa AM et al (2009) Management of primary pulmonary artery sarcomas. Ann Thorac Surg 87:977–984CrossRef Blackman SH, Rice DC, Correa AM et al (2009) Management of primary pulmonary artery sarcomas. Ann Thorac Surg 87:977–984CrossRef
14.
go back to reference Yin K, Zhanu Z, Luo R et al (2018) Clinical features and surgical outcomes of pulmonary artery sarcoma. J Thorac Cardiovasc Surg 155:1109–1115CrossRefPubMed Yin K, Zhanu Z, Luo R et al (2018) Clinical features and surgical outcomes of pulmonary artery sarcoma. J Thorac Cardiovasc Surg 155:1109–1115CrossRefPubMed
15.
go back to reference Penel N, Bui BN, Bay JO et al (2008) Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX study. J Clin Oncol 26:5269–5274CrossRef Penel N, Bui BN, Bay JO et al (2008) Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX study. J Clin Oncol 26:5269–5274CrossRef
17.
go back to reference Fujisawa Y, Yoshino K, Kadono T et al (2014) Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: a multicentre, retrospective study. Br J Dermatol 171:1493–1500CrossRef Fujisawa Y, Yoshino K, Kadono T et al (2014) Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: a multicentre, retrospective study. Br J Dermatol 171:1493–1500CrossRef
Metadata
Title
A case of pulmonary artery intimal sarcoma successfully treated using concurrent chemoradiotherapy and subsequent chemotherapy
Authors
Terumi Aso
Masako Terao
Hisashi Endo
Masahiro Tabata
Publication date
01-04-2019
Publisher
Springer Singapore
Published in
International Cancer Conference Journal / Issue 2/2019
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-018-00356-0

Other articles of this Issue 2/2019

International Cancer Conference Journal 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine